Actos
Designed to target elevated blood sugar, indicated to alleviate insulin resistance and support better glucose control in type 2 diabetes.
Strengths: 15 · 30mg
Where to Check Availability
Medicine details
- Conditions
- Therapeutic class
Thiazolidinedione
- Pharmacological class
Thiazolidinedione
- Minor side effects
weight gain; headache; upper respiratory tract infection
- Moderate side effects
peripheral oedema; visual disturbance; bone fractures
- Dosage forms
Tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Takeda
- Onset Time
2–4 weeks
- Duration
24 hours
- Storage instructions
Store at room temperature in a dry place.
- Drug interactions
insulin; sulfonylureas
- Age restrictions
Not recommended for children and adolescents.
- Pregnancy and breastfeeding
Not recommended during pregnancy; consult a physician.
Contraindications
hypersensitivity to pioglitazone; heart failure; hepatic impairment; diabetic ketoacidosis
Precautions and warnings
monitor for signs of fluid retention; liver function monitoring required; be aware of vision changes
Serious side effects
heart failure — requires immediate medical attention; bladder cancer symptoms — requires immediate medical attention
Patient summary
Designed to target elevated blood sugar, indicated to alleviate insulin resistance and support better glucose control in type 2 diabetes.
Mechanism of action
It works by activating PPAR-gamma receptors. This action increases the sensitivity of the body's cells to insulin, which promotes the uptake of glucose by target tissues such as muscle and adipose tissue.
Actos
Designed to target elevated blood sugar, indicated to alleviate insulin resistance and support better glucose control in type 2 diabetes.
Editorial Notes
- Active ingredient(s): Pioglitazone
- Listed indication(s): Type 2 Diabetes Mellitus
Usually available as
- 360 tablets - 15 mg46-15-mg-1870
- 120 tablets - 30 mg46-30-mg-1875